ToxSci Advance Access published online on May 5, 2004
Toxicological Sciences, doi:10.1093/toxsci/kfh159
Toxicological Sciences © Society of Toxicology 2004; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pathology and Microbiology, Havlik-Wall Professor of Oncology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, Nebraska 68198-3135
* To whom correspondence should be addressed. E-mail: scohen{at}unmc.edu.
An approach to the evaluation of carcinogenic risk resulting from exposure to a given chemical is presented in place of a reliance on two year rodent bioassays. An emphasis is placed on evaluation of the potential DNA reactivity or increased cell proliferation that can be produced by a chemical. The special cases of immunosuppressive and estrogenic chemicals are considered. These evaluations are proposed to involve a combination of in vitro assays, computerized models, and short term (up to 13 weeks) bioassays in rodents. The emphasis is on mechanistic understanding and evaluation of the dose response and relevance to humans.
Accepted April 21, 2004
Forum
Human Carcinogenic Risk Evaluation: An Alternative Approach to the Two-Year Rodent Bioassay
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. R. Fielden, R. Brennan, and J. Gollub A Gene Expression Biomarker Provides Early Prediction and Mechanistic Assessment of Hepatic Tumor Induction by Nongenotoxic Chemicals Toxicol. Sci., September 1, 2007; 99(1): 90 - 100. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jacobs Prediction of 2-Year Carcinogenicity Study Results for Pharmaceutical Products: How Are We Doing? Toxicol. Sci., November 1, 2005; 88(1): 18 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bucher and C. Portier Human Carcinogenic Risk Evaluation, Part V: The National Toxicology Program Vision for Assessing the Human Carcinogenic Hazard of Chemicals Toxicol. Sci., December 1, 2004; 82(2): 363 - 366. [Abstract] [Full Text] [PDF] |
||||
